Synthesis and characterization of a new cyclodextrin derivative with improved properties to design oral dosage forms

CODINA, ANA VICTORIA; HINRICHSEN, LUCILA I.; GARCÍA, AGUSTINA; VASCONI, MARÍA DELIA; LEONARDI, DARIO; PRIOTTI, JOSEFINA; QUIROGA, ARIEL D.; LAMAS, MARÍA CELINA

Drug Delivery and Translational Research

Springer US

Año: 2018 vol. 9 p. 273 - 283

2190-393X

This work aimed to synthesize a novel β-cyclodextrin derivative, itaconyl-β-cyclodextrin to evaluate whether albendazole inclusion complexes with the new β-cyclodextrin derivative-improved albendazole dissolution efficiency and its anthelminthic activity. The new derivative was thoroughly evaluated and characterized, and an average degree of substitution of 1.4 per cyclodextrin molecule was observed. Albendazole:itaconyl-β-cyclodextrin complexes were prepared by spray drying procedures and investigated using phase solubility diagrams, dissolution efficiency, X-ray diffraction, differential scanning calorimetry,Fourier transform infrared, scanning electronic microscopy, mass spectrometry, and nuclear magnetic resonance spectroscopy.Phase solubility diagrams and mass spectrometry studies showed that the inclusion complex was formed in an equimolar ratio.Stability constant values were 602 M−1 in water, and 149 M−1 in HCl 0.1 N. Nuclear magnetic resonance experiments of theinclusion complex showed correlation signals between the aromatic and propyl protons of albendazole and the itaconyl-β-cyclodextrin inner protons. The studies indicated solid structure changes of albendazole included in itaconyl-β-cyclodextrin.The maximum drug release was reached at 15 min, and the inclusion complex solubility was 88-fold higher than that of the puredrug. The in vitro anthelmintic activity assay showed that the complex was significantly more effective than pure albendazole.